Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase versus alteplase for acute ischaemic stroke
ACTRN12608000466347Phase 2Recruiting
- Sponsor
- John Hunter Hospital
- Start
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tenecteplase and tissue-plasminogen activator in brain infarction (3 arms), sponsored by John Hunter Hospital. Primary endpoints: Reperfusion and Early clinical improvement. Started Nov 2008; status: recruiting.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
brain infarction
Beyond the preview
Go deeper on ACTRN12608000466347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000466347.